Cystic fibrosis‐related diabetes
Tóm tắt
Diabetes mellitus (DM) has been recognized as a complication of cystic fibrosis (CF) for almost 50 years and commonly develops around 20 years of age. The prevalence increases with age and, with improved survival of those with CF, approaches 30% in certain centres. Its development appears to have a significant impact on pulmonary function and may increase mortality by up to six‐fold. Subjects with CF are rarely ketosis‐prone and phenotypically lie between Type 1 and Type 2 DM. Microvascular complications are recognized, although paucity of data does not permit a clear description of their natural history. An annual oral glucose tolerance test from the age of 10 years is recommended for screening, but logistical difficulties have led some groups to develop specific algorithms to aid diagnosis. Insulin sensitivity in CF is much debated and may depend upon the degree of glucose intolerance. Insulin resistance occurs in the presence of infection, corticosteroid usage and hyperglycaemia, whilst hepatic insulin resistance is considered an adaptation to CF. There is no universal consensus on the treatment of hyperglycaemia. With increased longevity of individuals with CF, greater numbers will develop diabetes and the diabetes physician is destined to play a greater role in the multidisciplinary CF team.
Diabet. Med. 20, 425–436 (2003)
Từ khóa
Tài liệu tham khảo
Lewis PA., 1995, Cystic Fibrosis, 1
Fanconi G, 1936, Das coeliakiesyndrom bei angeborener zysticher Pankreasfibromatose und Bronkiektasen, Wien Med Wochenschr, 86, 753
Landsteiner K., 1905, Darmverschluss durch eingedicktes Meconium. Pankreatitis, Zentrabl Allg Pathol, 16, 903
Garrod AE, 1912, Congenital familial steatorrhoea, Q J Med, 6, 242
Super M., 1992, Milestones in cystic fibrosis, Br Med Bull, 48, 717, 10.1093/oxfordjournals.bmb.a072574
Kristidis P, 1992, Genetic determinants of exocrine pancreas function in cystic fibrosis, Am J Hum Genet, 50, 1178
Hodson ME, 1995, Cystic Fibrosis
Yankaskas JR, 1999, Cystic Fibrosis in Adults.
Anderson CM., 1967, Long‐term study of patients with cystic fibrosis, Mod Probl Pediatr, 10, 344
Fredericksen B, 1996, Improved survival in the Danish center‐treated cystic fibrosis patients: results of aggressive treatment, Pediatr Pulmonol, 21, 153, 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R
Robert JJ, 1992, Reserche de facteurs d’intolerance au glucose dans la muscoviscidose, Arch Fr Pediatr, 49, 17
Charlton J, 2001, Setting up a diabetes/cystic fibrosis service, Diabet Med, 18, 100A
Lanng S, 2000, Diabetes mellitus in cystic fibrosis: a ten‐year prospective study, Diabetologia, 43, 107A
ZanelliP NeriTM De FantiA BoselliE GrzincichGL BetterleCet al.Genetic and immunological markers of preclinic insulin dependent diabetes mellitus (IDDM) in cystic fibrosis (CF). Workshop of Cystic Fibrosis Sestri Levante Italy1990.
Cystic Fibrosis Foundation Patient Registry., 1998, Annual Data Report.
Reisman J, 1990, Diabetes mellitus in patients with cystic fibrosis: effect on survival, Pediatrics, 86, 374, 10.1542/peds.86.3.374
Thornsteinsson B, 1991, Epidemiology of glucose intolerance in cystic fibrosis, Diabetes, 40, 320A
Green OC., 1983, Textbook of Cystic Fibrosis., 329
Gorvoy JD., 1617, Cataracts, arterio‐vascular calcifications, and retinopathy in a patient with cystic fibrosis and diabetes mellitus, Cystic Fibrosis Club Abstracts., 26, 178
Sullivan MM, 1989, Diabetic microangiopathy in patients with cystic fibrosis, Pediatrics, 84, 642, 10.1542/peds.84.4.642
Oppenheimer EH., 1972, Glomerular lesions in cystic fibrosis: possible relation to diabetes mellitus, acquired cyanotic heart disease and cirrhosis of the liver, John Hopkins Med J, 131, 351
Conway SP, 2000, Cystic Fibrosis in Children and Adults: The Leeds Method of Management.
Abdul‐Karim FW, 1986, Islets of Langerhans in adolescents and adults with cystic fibrosis, Arch Pathol Lab Med, 110, 602
Matthews DR, 1997, Textbook of Diabetes., 21.1
Wilmhurst EG, 1975, Endogenous and exogenous insulin response in patients with cystic fibrosis, Pediatrics, 55, 75, 10.1542/peds.55.1.75
Lanng S., 1997, Glucose intolerance in cystic fibrosis, Dan Med Bull, 44, 23
Larsen S, 1988, Pancreatic hormone secretion in chronic pancreatitis without residual beta‐cell function, Acta Endocrinol, 118, 357
Nousia‐Arvanitakis S, 1985, Pancreatic polypeptide in cystic fibrosis, Arch Pathol Lab Med, 109, 722
Mohan V, 1985, Insulin and C‐peptide responses to glucose load in cystic fibrosis, Diabet Metab, 11, 376
Flatt JP., 1978, The biochemistry of energy expenditure, Rec Adv Obes Res, 2, 211
Figuero V, 2002, Abnormal lipid concentrations in cystic fibrosis, Am J Clin Nutr, 75, 1005, 10.1093/ajcn/75.6.1005
Moran A., 1998, Highlights of the February 1998 consensus conference on CFRD, Paediatr Pulmonol, 104
1990, Cystic Fibrosis Foundation Conference on CF‐Related Diabetes Mellitus, Tysons Corner, VA, 11–12 January 1990., 1
Ashworth FA, 1999, The management of cystic fibrosis related diabetes, Br J Homecare, 1, 136
Metropolitan height and weight tables.Stat Bull Metrop Life Found1983;64:3–9.
Yacoub MY, 1990, Heart‐lung transplant for cystic fibrosis and subsequent domino heart transplant, J Heart Transpl, 9, 459
Ramirez JC, 1992, Bilateral lung transplantation for cystic fibrosis, J Thorac Cardiovasc Surg, 103, 287, 10.1016/S0022-5223(19)35030-5
Kent NE, 1993, Cystic fibrosis and pregnancy, Can Med Assoc J, 149, 809
Luder E, 1990, Current recommendations for breast feeding in cystic fibrosis centres, Am J Dis Child, 144, 1153
FitzSimmons SC, 1996, A longitudinal study of the effects of pregnancy on 325 women with cystic fibrosis, Pediatr Pulmonol Suppl, 13, 99
McFadyen IR., 1995, Turnbull's Obstetrics, 115
Zipf W., 1995, Therapeutic options for treatment of diabetes mellitus in cystic fibrosis, Paediatr Pulmonol Suppl, 5, 111